Cargando…
Berberine exerts a protective effect on rats with polycystic ovary syndrome by inhibiting the inflammatory response and cell apoptosis
BACKGROUND: Polycystic ovary syndrome (PCOS) is a common endocrine disease of the female reproductive system that seriously affects women’s health. Berberine (BBR) has many pharmacological properties and is used as an insulin sensitizer. This study aimed to investigate the effect of BBR on PCOS and...
Autores principales: | Shen, Hao-Ran, Xu, Xiao, Li, Xue-Lian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789273/ https://www.ncbi.nlm.nih.gov/pubmed/33407557 http://dx.doi.org/10.1186/s12958-020-00684-y |
Ejemplares similares
-
Protective effects of berberine in a rat model of polycystic ovary syndrome mediated via the PI3K/AKT pathway
por: Yu, Jia, et al.
Publicado: (2021) -
The role of serum inflammatory cytokines and berberine in the insulin signaling pathway among women with polycystic ovary syndrome
por: Kuang, Hongying, et al.
Publicado: (2020) -
The Effect of Berberine on Polycystic Ovary Syndrome Patients with Insulin Resistance (PCOS-IR): A Meta-Analysis and Systematic Review
por: Li, Meng-Fei, et al.
Publicado: (2018) -
Polycystic ovary syndrome management: a review of the possible amazing role of berberine
por: Rondanelli, M., et al.
Publicado: (2020) -
Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
por: Wang, Yu, et al.
Publicado: (2016)